Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 10 Added 3.13% |
$1,870
$187.0 p/Share
|
Mar 08
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 350 Added 9.62% |
$68,775
$196.5 p/Share
|
Mar 08
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 1,000 Added 40.0% |
$182,000
$182.0 p/Share
|
Mar 04
2010 |
SPOK
|
Vincent D Kelly
President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 25,658 Reduced 18.51% |
$288,909
$11.26 p/Share
|
Mar 04
2010 |
SPOK
|
Vincent D Kelly
President & CEO |
BUY
Grant, award, or other acquisition
|
Direct | 60,799 Added 30.49% |
$684,597
$11.26 p/Share
|
Mar 04
2010 |
SPOK
|
Matthew Oristano
Director |
SELL
Open market or private sale
|
Direct | 864 Reduced 19.55% |
$10,385
$12.02 p/Share
|
Mar 03
2010 |
NP
|
Philip C Moore
Director |
BUY
Other acquisition or disposition
|
Direct | 14 Added 50.0% |
$228
$16.28 p/Share
|
Mar 02
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 200 Added 28.57% |
$36,172
$180.86 p/Share
|
Mar 02
2010 |
FCAP
|
Dennis L Huber
Director |
SELL
Bona fide gift
|
Direct | 1,540 Reduced 70.51% |
-
|
Mar 02
2010 |
AYI
|
Vernon J Nagel
Executive Chairman |
SELL
Open market or private sale
|
Direct | 12,301 Reduced 5.28% |
$486,259
$39.53 p/Share
|
Mar 02
2010 |
AYI
|
Vernon J Nagel
Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct | 12,301 Added 5.02% |
$145,767
$11.85 p/Share
|
Mar 02
2010 |
MDC
|
Larry A Mizel
Executive Chairman |
BUY
Other acquisition or disposition
|
Indirect | 594,000 Added 50.0% |
$13,513,500
$22.75 p/Share
|
Mar 01
2010 |
MDC
|
Larry A Mizel
Executive Chairman |
SELL
Other acquisition or disposition
|
Indirect | 594,000 Reduced 99.0% |
$13,513,500
$22.75 p/Share
|
Mar 01
2010 |
IOGPQ
|
Robert P Peebler
Executve Chairman |
BUY
Grant, award, or other acquisition
|
Direct | 12,215 Added 2.65% |
-
|
Mar 01
2010 |
AYI
|
Vernon J Nagel
Executive Chairman |
SELL
Open market or private sale
|
Direct | 35,904 Reduced 14.0% |
$1,423,953
$39.66 p/Share
|
Mar 01
2010 |
AYI
|
Vernon J Nagel
Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct | 35,904 Added 12.28% |
$425,462
$11.85 p/Share
|
Mar 01
2010 |
AYI
|
Vernon J Nagel
Executive Chairman |
SELL
Open market or private sale
|
Direct | 200 Reduced 0.09% |
$7,900
$39.5 p/Share
|
Feb 26
2010 |
AYI
|
Vernon J Nagel
Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct | 200 Added 0.09% |
$2,370
$11.85 p/Share
|
Feb 26
2010 |
IDIX
|
Ag Novartis |
BUY
Open market or private purchase
|
Indirect | 1,872 Added 0.01% |
$4,512
$2.41 p/Share
|
Feb 26
2010 |
IOGPQ
|
James M Lapeyre Jr
Director |
BUY
Open market or private purchase
|
Direct | 50,000 Added 3.09% |
$218,000
$4.36 p/Share
|
Feb 24
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 150 Added 33.33% |
$26,850
$179.0 p/Share
|
Feb 24
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 150 Added 50.0% |
$27,300
$182.0 p/Share
|
Feb 23
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 193 Added 1.68% |
$34,161
$177.0 p/Share
|
Feb 22
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 604 Added 36.78% |
$105,313
$174.36 p/Share
|
Feb 16
2010 |
V
|
Elizabeth Buse
EVP GLOBAL SOLUTIONS |
BUY
Exercise of conversion of derivative security
|
Direct | 31,599 Added 41.78% |
$1,390,356
$44.0 p/Share
|
Feb 12
2010 |
V
|
Elizabeth Buse
EVP GLOBAL SOLUTIONS |
SELL
Open market or private sale
|
Direct | 31,599 Reduced 71.76% |
$2,662,216
$84.25 p/Share
|
Feb 12
2010 |
MAS
|
William T Anderson
VP-Controller |
BUY
Grant, award, or other acquisition
|
Direct | 30,000 Added 18.13% |
-
|
Feb 12
2010 |
MAS
|
Donald J De Marie Jr
Executive Vice President & COO |
BUY
Grant, award, or other acquisition
|
Direct | 93,000 Added 18.0% |
-
|
Feb 12
2010 |
MAS
|
Charles F Greenwood
VP-Human Resources |
BUY
Grant, award, or other acquisition
|
Direct | 23,000 Added 21.26% |
-
|
Feb 12
2010 |
MAS
|
Richard A Manoogian
Director |
BUY
Grant, award, or other acquisition
|
Direct | 77,000 Added 1.19% |
-
|
Feb 12
2010 |
MAS
|
John G Sznewajs
VP and CFO |
BUY
Grant, award, or other acquisition
|
Direct | 40,000 Added 16.47% |
-
|
Feb 12
2010 |
MAS
|
Timothy Wadhams
Director |
BUY
Grant, award, or other acquisition
|
Direct | 167,000 Added 16.62% |
-
|
Feb 12
2010 |
MAS
|
Gregory Dale Wittrock
VP - General Counsel and Sec. |
BUY
Grant, award, or other acquisition
|
Direct | 15,000 Added 17.26% |
-
|
Feb 12
2010 |
FCAP
|
Dennis L Huber
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,540 Added 41.35% |
$15,400
$10.0 p/Share
|
Feb 12
2010 |
FCAP
|
Samuel E Uhl
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 6,875 Added 26.11% |
$68,750
$10.0 p/Share
|
Feb 12
2010 |
FCAP
|
Joel E Voyles
Senior Vice President |
BUY
Exercise of conversion of derivative security
|
Direct | 3,300 Added 21.99% |
$33,000
$10.0 p/Share
|
Feb 12
2010 |
FCAP
|
Chris Frederick
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct | 1,320 Reduced 75.82% |
$18,810
$14.25 p/Share
|
Feb 12
2010 |
CHTT
|
Sanofi
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 923,268 Added 1.95% |
$86,325,558
$93.5 p/Share
|
Feb 11
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 100 Added 25.0% |
$17,066
$170.66 p/Share
|
Feb 10
2010 |
CHTT
|
Sanofi
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 300,936 Added 0.66% |
$28,137,516
$93.5 p/Share
|
Feb 10
2010 |
CHTT
|
Sanofi
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 29,417,226 Added 20.24% |
$2,750,510,631
$93.5 p/Share
|
Feb 09
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 100 Added 3.4% |
$17,300
$173.0 p/Share
|
Feb 08
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 200 Added 50.0% |
$34,304
$171.52 p/Share
|
Feb 08
2010 |
FCAP
|
William W Harrod
CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct | 4,000 Added 29.25% |
$40,000
$10.0 p/Share
|
Feb 05
2010 |
FCNCA
|
Lewis T Nunnelee Ii
Director |
SELL
Bona fide gift
|
Direct | 300 Reduced 50.0% |
-
|
Feb 04
2010 |
MDC
|
Larry A Mizel
Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct | 60,000 Added 25.0% |
-
|
Feb 04
2010 |
MDC
|
David D Mandarich
President, CEO and Director |
BUY
Grant, award, or other acquisition
|
Direct | 60,000 Added 1.98% |
-
|
Feb 04
2010 |
AMKR
|
Joanne Solomon
Executive VP & CFO |
BUY
Grant, award, or other acquisition
|
Direct | 20,000 Added 46.78% |
-
|
Feb 03
2010 |
MEI
|
Timothy Glandon
Vice President |
BUY
Open market or private purchase
|
Direct | 21 Added 0.6% |
$232
$11.04 p/Share
|
Jan 29
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
SELL
Bona fide gift
|
Indirect | 201,093 Reduced 100.0% |
-
|
Jan 29
2010 |